Showing results (51-60 of 87) with videos related to
Sort By:
Pageof 9
Journal of Immunological Methods|November 11, 1983
Measurement of specific antibodies in human intestinal aspirate: effect of the protease inhibitor phenylmethylsulphonyl fluorideA Hohmann, J LaBrooy, G P Davidson, et al.Clinical and Experimental Immunology|November 1, 1991
The H3 anti-phospholipid idiotype is found in patients with systemic lupus erythematosus (SLE) but not in patients with syphilisA Hohmann, R Comacchio, V Boswarva, et al.Pharmacy (Basel, Switzerland)|December 22, 2022
Public Perceptions of Community Pharmacy-Based Naloxone Services: A National Cross-Sectional SurveyLindsey A Hohmann, Zach Krauss, Jitisha Patel, et al.Scandinavian Journal of Immunology|August 1, 1991
Impaired balance of interleukin-4 and interferon-gamma production in infections with Schistosoma mansoni and intestinal nematodesK Zwingenberger, A Hohmann, M C de Brito, et al.Journal of the American Pharmacists Association : Japha|March 4, 2019
A pharmacy-based referral program to assist low-income Medicare beneficiariesTessa J Hastings, Lindsey A Hohmann, Jan Neal, et al.The Journal of Diabetic Complications|October 1, 1988
Atrial natriuretic factor in various stages of diabetic nephropathyP T Sawicki, L Heinemann, K Rave, et al.Autoimmunity|January 1, 1995
Immunoglobulin gene sequence analysis of anti-cardiolipin and anti-cardiolipin idiotype (H3) human monoclonal antibodiesA Hohmann, E Cairns, M Brisco, et al.Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|June 27, 2000
Similar-other support for men undergoing coronary artery bypass surgeryP A Thoits, A A Hohmann, M R Harvey, et al.Clinical and Experimental Immunology|February 1, 1989
A common anti-cardiolipin antibody idiotype in autoimmune disease: identification using a mouse monoclonal antibody directed against a naturally-occurring anti-phospholipid antibodyM Sutjita, A Hohmann, R Comacchio, et al.Leukemia Research|October 31, 2001
Antibody against CD20 in patients with B cell malignancyP J Adamson, H Zola, I C Nicholson, et al.Pageof 9